These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37650576)

  • 21. Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.
    von Schuckmann LA; Hughes MCB; Ghiasvand R; Malt M; van der Pols JC; Beesley VL; Khosrotehrani K; Smithers BM; Green AC
    JAMA Dermatol; 2019 Jun; 155(6):688-693. PubMed ID: 31042258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    Bleicher J; Swords DS; Mali ME; McGuire L; Pahlkotter MK; Asare EA; Bowles TL; Hyngstrom JR
    J Surg Oncol; 2020 Dec; 122(8):1770-1777. PubMed ID: 33098702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic burden of recurrence in elderly patients with completely resected, stage IIB/IIC or III melanoma: an analysis of the Surveillance, Epidemiology, and End Results-Medicare linked database.
    Jiang R; Wang T; Liu Y; Kumar A; Shen P; Fukunaga-Kalabis M; Ayyagari R
    J Med Econ; 2024; 27(1):1279-1292. PubMed ID: 39358312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yield of baseline imaging for distant metastases in high-risk primary melanoma.
    Yan MK; Adler NR; Pan Y; Chamberlain A; Kelly J; Yap K; Voskoboynik M; Haydon A; Shackleton M; Mar VJ
    J Surg Oncol; 2022 Jun; 125(8):1312-1317. PubMed ID: 35262187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma.
    Samlowski W; Silver MA; Hohlbauch A; Zhang S; Fukunaga-Kalabis M; Krepler C; Wang Y; Sruti I; Jiang R
    Melanoma Res; 2024 Aug; 34(4):326-334. PubMed ID: 38814728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
    Lee AY; Droppelmann N; Panageas KS; Zhou Q; Ariyan CE; Brady MS; Chapman PB; Coit DG
    Ann Surg Oncol; 2017 Apr; 24(4):939-946. PubMed ID: 27804026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.
    Haydu LE; Scolyer RA; Lo S; Quinn MJ; Saw RPM; Shannon KF; Spillane AJ; Stretch JR; McCarthy WH; Thompson JF
    J Clin Oncol; 2017 May; 35(15):1721-1729. PubMed ID: 28375785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
    Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
    JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study.
    Straker RJ; Sharon CE; Chu EY; Miura JT; Ming ME; Karakousis GC
    J Am Acad Dermatol; 2022 Oct; 87(4):754-760. PubMed ID: 35469980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB.
    Amaral T; Nanz L; Stadler R; Berking C; Ulmer A; Forschner A; Meiwes A; Wolfsperger F; Meraz-Torres F; Chatziioannou E; Martus P; Flatz L; Garbe C; Leiter U
    Eur J Cancer; 2024 Apr; 201():113912. PubMed ID: 38368742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
    Saw SPL; Zhou S; Chen J; Lai G; Ang MK; Chua K; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Lim DWT; Tan A; Fong KW; Takano A; Cheng XM; Lim KH; Koh T; Ong BH; Tan EH; Toh CK; Skanderup AJ; Tan SH; Tan DSW
    JAMA Netw Open; 2021 Nov; 4(11):e2131892. PubMed ID: 34739062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence.
    Rockberg J; Amelio JM; Taylor A; Jörgensen L; Ragnhammar P; Hansson J
    Int J Cancer; 2016 Dec; 139(12):2722-2729. PubMed ID: 27563839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stage-specific disease recurrence and survival in localized and regionally advanced cutaneous melanoma.
    Leeneman B; Franken MG; Coupé VMH; Hendriks MP; Kruit W; Plaisier PW; van Ruth S; Verstijnen JAMC; Wouters MWJM; Blommestein HM; Uyl-de Groot CA
    Eur J Surg Oncol; 2019 May; 45(5):825-831. PubMed ID: 30765270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma.
    Kukar M; Gabriel E; May R; Cho E; Lichtenthal M; Groman A; Skitzki J; Francescutti V; Kane JM
    Am Surg; 2017 Nov; 83(11):1256-1262. PubMed ID: 29183528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
    Eggermont AMM; Blank CU; Mandalà M; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; van Akkooi ACJ; Krepler C; Ibrahim N; Marreaud S; Kicinski M; Suciu S; Robert C;
    Lancet Oncol; 2021 May; 22(5):643-654. PubMed ID: 33857412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program.
    Tjokrowidjaja A; Browne L; Soudy H
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e280-e288. PubMed ID: 34811927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.